Woodline Partners LP - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$133,321
-80.6%
724,571
+26.2%
0.00%
-75.0%
Q2 2023$685,913
-4.7%
573,986
-17.9%
0.01%
-20.0%
Q3 2022$720,000
-8.6%
699,266
-39.7%
0.01%
-16.7%
Q2 2022$788,000
-66.5%
1,158,956
-58.7%
0.01%
-68.4%
Q1 2022$2,349,000
-64.4%
2,803,230
-30.7%
0.04%
-59.6%
Q4 2021$6,597,000
-37.5%
4,047,231
-7.6%
0.09%
-45.3%
Q3 2021$10,554,000
+31.3%
4,379,396
+43.8%
0.17%
+14.7%
Q2 2021$8,037,000
+126.5%
3,044,432
+328.0%
0.15%
+89.9%
Q1 2021$3,549,000711,2380.08%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders